Esperion Therapeutics, Inc. (ESPR)

Import this data to Google Sheets with:

=jivedata("ESPR","financials")

Full statements spill as a table. For one cell: =jivedata("ESPR","Revenue") or =jivedata("ESPR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Esperion Therapeutics, Inc.

ESPR • CIK 0001434868

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-155,563	$54,402	$60,273	$75,788
InterestExpenseNonoperating	—	$59,251	$84,604	$84,971
Gain (Loss) on Extinguishment of Debt	—	$-54,918	$0	$0
Other Nonoperating Income (Expense)	$5,291	$8,022	$3,490	$3,601
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	$-20,841	$-20,841
Income Tax Expense (Benefit)	$0	$0	$1,841	$1,841
Net Income (Loss) Attributable to Parent	$-209,248	$-51,745	$-22,682	$-7,423
Weighted Average Number of Shares Outstanding, Basic	103,106,616	187,181,856	207,865,080	263,090,218
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-209,246	$-51,745	$-22,682	$-7,423
Revenue from Contract with Customer, Excluding Assessed Tax	$116,334	$332,314	$403,135	$418,244
Operating Costs and Expenses	—	—	$129,224	$129,224
Research and Development Expense (Excluding Acquired in Process Cost)	$86,107	$46,238	$47,852	$44,283
Selling, General and Administrative Expense	$142,523	$163,073	$165,786	$165,914
Operating Expenses	$271,897	$277,912	$342,862	$342,456
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	$2	$0	$0	$0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$82,248	$144,761	$167,852	$156,158
Accounts Receivable, after Allowance for Credit Loss, Current	$48,494	$80,142	$140,190	$132,352
Property, Plant and Equipment, Net	$0	$254	$338	$311
Inventory, Net	$65,623	$94,491	$105,124	$104,209
Operating Lease, Right-of-Use Asset	$4,675	$5,513	$2,922	$2,701
Intangible Assets, Net (Including Goodwill)	$56	$56	$56	$56
Assets	$205,796	$343,821	$465,886	$462,529
Prepaid Expense and Other Assets, Current	$4,507	$18,018	$4,496	$6,023
Assets, Current	$201,065	$337,998	$462,570	$459,461
Convertible Notes Payable, Noncurrent	$261,596	$96,745	$97,260	$97,394
Other Long-term Debt, Noncurrent	—	$140,971	$152,219	$152,674
Operating Lease, Liability, Noncurrent	$3,020	$2,570	$653	$861
Other Liabilities, Noncurrent	—	—	$8,739	$8,739
Liabilities	$660,790	$732,543	$767,851	$770,460
Accounts Payable, Current	$31,718	$51,650	$65,068	$68,406
Convertible Notes Payable, Current	—	$54,575	$0	$0
Contract with Customer, Liability, Current	$25,402	$8,518	$34,477	$43,531
Operating Lease, Liability, Current	$1,553	$2,741	$2,102	$1,699
Liabilities, Current	$156,224	$246,233	$300,810	$300,359
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$118	$196	$245	$257
Additional Paid in Capital	$1,149,170	$1,267,109	$1,376,499	$1,395,717
Treasury Stock, Common, Value	$54,998	$54,998	$54,998	$54,998
Retained Earnings (Accumulated Deficit)	$-1,549,284	$-1,601,029	$-1,623,711	$-1,648,907
Stockholders' Equity Attributable to Parent	$-454,994	$-388,722	$-301,965	$-307,931
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	480,000,000	480,000,000	480,000,000	480,000,000
Common Stock, Shares, Issued	120,204,513	197,846,661	247,210,341	259,399,074
Treasury Stock, Common, Shares	1,994,198	1,994,198	1,994,198	1,994,198
Lessee, Operating Lease, Liability, to be Paid, Year One	$1,838	$3,061	$2,213	$2,213
Lessee, Operating Lease, Liability, to be Paid, Year Two	$1,811	$2,307	$440	$440
Lessee, Operating Lease, Liability, to be Paid, Year Three	$1,140	$241	$258	$258
Lessee, Operating Lease, Liability, to be Paid, Year Four	$169	$144	$0	$0
Lessee, Operating Lease, Liability, to be Paid, Year Five	$144	$0	$0	$0
Lessee, Operating Lease, Liability, to be Paid	$5,102	$5,753	$2,911	$2,911
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	$529	$442	$156	$156
Operating Lease, Liability	$4,573	$5,311	$2,755	$2,755

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-209,248	$-51,745	$-22,682	$-7,423
Net Cash Provided by (Used in) Operating Activities	$-135,487	$-23,654	$-13,093	$-18,187
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-42,527	$62,513	$23,091	$41,525
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$82,248	$144,761	$167,852	$209,377
Gain (Loss) on Extinguishment of Debt	—	$-54,918	$0	$0
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$42,500	$0	$0	$0
Payments to Acquire Property, Plant, and Equipment	—	$317	$0	$189
Paid-in-Kind Interest	—	—	$9,093	$9,093
Net Cash Provided by (Used in) Investing Activities	$42,500	$-317	$0	$-189
Share-based Payment Arrangement, Noncash Expense	$11,958	$11,993	$9,870	$9,907
Depreciation	$164	$63	$105	$106
Accretion (Amortization) of Discounts and Premiums, Investments	$412	$0	$0	$0
Amortization of Debt Issuance Costs and Discounts	$1,697	$1,498	$3,007	$2,897
Payments of Debt Issuance Costs	—	—	$0	$0
Proceeds from Lines of Credit	—	$145,376	$0	$0
Proceeds from Issuance of Debt	—	$99,726	$0	$0
Repayments of Convertible Debt	—	$210,088	$54,912	$54,912
Proceeds from Warrant Exercises	$9,069	$14,808	$10,348	$26,565
Payments of Stock Issuance Costs	—	—	$7,500	$0
Proceeds from (Payments for) Other Financing Activities	—	$29	$244	$244
Net Cash Provided by (Used in) Financing Activities	$50,460	$86,484	$36,184	$59,901
Capital Expenditures Incurred but Not yet Paid	—	—	$189	$189
Income Taxes Paid, Net	—	—	$612	$612
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$16,266	$16,266
Increase (Decrease) in Accounts Receivable	$14,765	$31,648	$60,048	$51,058
Increase (Decrease) in Prepaid Expense and Other Assets	$-6,192	$13,904	$30,800	$43,213
Increase (Decrease) in Contract with Customer, Liability	$21,895	$-16,884	$25,959	$25,959
Increase (Decrease) in Inventories	$30,422	$28,868	$10,633	$4,887
Increase (Decrease) in Accounts Payable	$8,678	$12,432	$20,918	$-3,588
Increase (Decrease) in Other Accrued Liabilities	$22,097	$18,342	$31,223	$27,291
Increase (Decrease) in Other Noncurrent Liabilities	—	—	$8,739	$8,739

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ESPR","financials")

Full statements spill as a table. For one cell: =jivedata("ESPR","Revenue") or =jivedata("ESPR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.